Gladstone Institutes Welcomes Bill Price as Its Newest Trustee
It is a historic time at the Gladstone Institutes; William S. “Bill” Price, III, has joined the Gladstone Trustees. Price replaces Albert A. Dorman, who served Gladstone for almost 30 years.
Although new as a Trustee, Price has been involved with Gladstone for many years, beginning in 2004 as a member of the Gladstone Advisory Council.
“Gladstone is an extraordinary research organization with a stellar record of scientific achievements,” said Price. “I look forward to these new responsibilities and the opportunity to contribute to Gladstone’s mission of overcoming major unsolved diseases.”
Price is a co-founder and partner emeritus of TPG Capital, LP (formerly Texas Pacific Group), a private equity fund founded in 1992 with over $30 billion in assets under management. He is now deeply involved in the wine industry as the proprietor of Price Family Vineyards & Estates, a collection of wineries along the Sonoma Coast.
Price is an active philanthropist with several organizations. He has served as board chair of the Gladstone Foundation since its inception in 2011. He is also chair of Common Sense Media, a nonprofit organization that works with families, educators, policy makers, and business leaders to help children thrive in a world of media and technology.
“Bill has had a very successful and exciting career,” said Gladstone Trustee Richard D. Jones. “His sound judgment, extensive experience, and great enthusiasm make him a wonderful addition to Gladstone.”
Trustee Andrew S. Garb added, “Bill has been a great leader over the years. His dedication has helped us pursue new avenues and achieve new heights. We are fortunate to have Bill in this new role, where he can have an even deeper impact.”
Designated as a three-person team by J. David Gladstone’s trust, the Trustees strategically guide Gladstone to ensure financial strength and foster and enrich innovation, talent, and entrepreneurship. The last time Gladstone had a new trustee was in 2004 when Garb joined the team.
“Since the founding of Gladstone, the Trustees have guided Gladstone into the thriving organization that it is today,” said Gladstone President R. Sanders “Sandy” Williams, MD. “Bill’s contributions will undoubtedly continue that growth and prominence in the years ahead.
Up Next
Meet Gladstone: Ayush Midha
Ayush Midha, a graduate student in the Jain Lab, studies how the body's metabolism adapts to low oxygen—work that's uncovered backup energy pathways, potential fertility treatments, and a link between oxygen levels and tumor growth.
How a Single Viral Protein Hijacks Immune Cells to Supercharge COVID-19 Infection
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy for therapeutic intervention.
Rethinking ‘Exhausted’ T Cells: Gilbert Herrera Named Inaugural Ellen & Bernard Marson Fellow
The fellowship provides three years of funding for graduate students pursuing groundbreaking immunology research.
The 2026 Ogawa-Yamanaka Stem Cell Prize Awarded to Jun Takahashi
Takahashi is recognized for his pioneering work translating iPS cell technology into a clinically approved therapy for Parkinson’s disease.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now